The clinical features, cytokine profile, lower naïve CD4 T cell numbers, and presence of autoantibodies place MIS-C at the intersection of severe COVID-19 infection and Kawasaki disease [16,17]. This evidence concerns the gene CD4 and Kawasaki disease.